Back to Massachusetts

H2372 • 2025

An Act relative to collaborative drug therapy management optimization

An Act relative to collaborative drug therapy management optimization

Active

The official status still shows this bill as active or still awaiting another formal step.

Sponsor
Christine P. Barber
Last action
2026-04-15
Official status
Referred to House Committee on Ways and Means
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

An Act relative to collaborative drug therapy management optimization

An Act relative to collaborative drug therapy management optimization By Representative Barber of Somerville, a petition (accompanied by bill, House, No.

What This Bill Does

  • An Act relative to collaborative drug therapy management optimization By Representative Barber of Somerville, a petition (accompanied by bill, House, No.
  • 2372) of Christine P.
  • Barber and Patrick Joseph Kearney relative to collaborative drug therapy management optimization.
  • Public Health.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-04-15 House

    Committee recommended bill ought to pass and referred to the committee on House Ways and Means

  2. 2026-03-19 House

    Reporting date extended to Monday, June 15, 2026

  3. 2025-12-08 House

    Reporting date extended to Wednesday, March 18, 2026

  4. 2025-07-24 House

    Reported favorably by committee and referred to the committee on Health Care Financing

  5. 2025-06-06 Joint

    Hearing scheduled for 06/11/2025 from 01:00 PM-05:00 PM in A-1

  6. 2025-02-27 House

    Referred to the committee on Public Health

  7. 2025-02-27 Senate

    Senate concurred

Official Summary Text

An Act relative to collaborative drug therapy management optimization
By Representative Barber of Somerville, a petition (accompanied by bill, House, No. 2372) of Christine P. Barber and Patrick Joseph Kearney relative to collaborative drug therapy management optimization. Public Health.
Status:
Referred to House Committee on Ways and Means

Current Bill Text

Read the full stored bill text
×

Bill H.2372

Notwithstanding section 24 B1/2 of chapter 112 of the General Laws or any other general or special laws to the contrary, collaborative drug therapy management may be allowed in ambulatory care clinics licensed pursuant to section 51 of chapter 111 of the General Laws if: (i) there is on-site or off-site supervision by the attending physician and a collaborating pharmacist; and (ii) collaborative drug therapy management is approved by the ambulatory care clinic's medical staff executive committee or designee or medical director or designee.

The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

Close